Programs promoting timely sequential antimicrobial therapy: an American perspective.
Interventional programs promoting the timely conversion of intravenous to oral antimicrobial therapy have been reported from several hospitals in the U.S.A. and elsewhere. Factors influencing the initiation and conduct of these programs include technological advances, changes in health care delivery or reimbursement, publication of supportive clinical data and growth of clinical pharmacy services. Successful programs employ comprehensive, multidisciplinary strategies to contain antimicrobial-related expenditures using interventions based on structured criteria. Future emphasis on cost-effective drug therapy, advances in computer-based information technology and development of care maps can have favourable influences on the growth of these programs in the U.S.A.
Drew
R H
RH
Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000191:economics; D003141:Communicable Diseases / Q000188:drug therapy* / Q000382:microbiology; D016527:Drug Costs; D006801:Humans; D008137:Longitudinal Studies; D015337:Multicenter Studies as Topic; D015397:Program Evaluation / Q000639:trends*; D014481:United States
D000900:Anti-Bacterial Agents